+7 (343) 270-75-00

          info@uphc.ru

News

On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.

The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.

On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.

More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.

Triton-Electronic Systems LTD

Triton-ElectronicS was founded in 1989 It is the largest Russian developer and manufacturer of medical equipment for anesthesiology and emergency medicine. In terms of clinical performance, our devices meet the standards of world leaders, and at the same time, they are a more efficient choice in terms of cost of ownership.

Achievements of Triton ElectronicS in the field of development of medical equipment and technologies are closely connected with the name of Professor Boris Davidovich Zislin. B.D. Zislin was the chief anesthetist of the Sverdlovsk Region for 37 years. His innovative ideas have contributed to the development of innovative medical technologies and the organization of the production of a number of medical devices for anesthesiology and emergency medicine.

Triton-ElectronicS creates unique and fundamentally new solutions for the global medical equipment market. These solutions are simple, easy to use and reliable. The company creates the solutions needed by the modern consumer.

ALV devices of JV100 series for high-frequency jet ventilation and MV300 series for conventional ventilation. In addition to the standard ventilation modes, the Zisline MV300 ventilator features the iSV adaptive ventilation mode, which provides maximum patient comfort, and also allows adapting the patient to the transition to spontaneous breathing efficiently and safely – the parameters are adjusted according to respiratory monitoring data. The device also allows assessing the true metabolic needs of the patient by indirect calorimetry.

The specialized single-channel monitor MGA-06 is designed for evaluation and long-term monitoring of the anaesthetic depth and sedation level of the patient. It is used during anesthesia and sedation in the intensive care unit. The main parameter to be determined is the brain activity index (AI).

 

MPR6-03 patient monitors provide monitoring of 5 main parameters (Harvard Standard), as well as additional monitoring: analysis of anesthetic gases, assessment of the anaesthetic depth and sedation level, non-invasive assessment of central hemodynamic parameters, monitoring of CO2 in the forward and lateral flows, including volumetric capnometry, assessment of the true metabolic needs of the patient, respiratory mechanics, monitoring of invasive pressures, including low ones.

12/5, Sibirsky Tract, Ekaterinburg

Tel.: + (343) 304-60-50

Е-mail: mail@triton.ru

www.triton.ru